Dong‐Sook Kim

1.6k total citations · 1 hit paper
78 papers, 1.1k citations indexed

About

Dong‐Sook Kim is a scholar working on Economics and Econometrics, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Dong‐Sook Kim has authored 78 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Economics and Econometrics, 16 papers in Epidemiology and 14 papers in Applied Microbiology and Biotechnology. Recurrent topics in Dong‐Sook Kim's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Antibiotic Use and Resistance (14 papers) and Pharmaceutical Economics and Policy (14 papers). Dong‐Sook Kim is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Antibiotic Use and Resistance (14 papers) and Pharmaceutical Economics and Policy (14 papers). Dong‐Sook Kim collaborates with scholars based in South Korea, Japan and United States. Dong‐Sook Kim's co-authors include Jee-Ae Kim, Seok‐Jun Yoon, Log Young Kim, SeungJin Bae, Euna Han, Hyun Jung Kim, Hyeong Sik Ahn, Nayoung Kim, Sung Woo Jung and Ki‐Nam Shim and has published in prestigious journals such as PLoS ONE, Stroke and Scientific Reports.

In The Last Decade

Dong‐Sook Kim

71 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data

2017 512 citations Dong‐Sook Kim et al. Journal of Korean Medical Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dong‐Sook Kim South Korea	15	259	196	153	131	125	78	1.1k
Pawana Sharma United Kingdom	19	295 1.1×	190 1.0×	120 0.8×	168 1.3×	59 0.5×	34	1.6k
A.‐P. Jonville‐Béra France	24	259 1.0×	164 0.8×	76 0.5×	139 1.1×	137 1.1×	136	1.8k
Deborah R. Kaye United States	18	346 1.3×	70 0.4×	158 1.0×	207 1.6×	67 0.5×	68	856
Ishak A. Mansi United States	19	514 2.0×	180 0.9×	149 1.0×	150 1.1×	50 0.4×	77	1.2k
Jee-Ae Kim South Korea	9	186 0.7×	204 1.0×	82 0.5×	194 1.5×	41 0.3×	12	1.2k
Valentina Perrone Italy	19	154 0.6×	177 0.9×	91 0.6×	128 1.0×	62 0.5×	128	1.1k
Jamie P. Traynor United Kingdom	22	361 1.4×	213 1.1×	101 0.7×	287 2.2×	33 0.3×	69	2.0k
Mark Nuijten Netherlands	22	179 0.7×	280 1.4×	252 1.6×	349 2.7×	100 0.8×	72	1.5k
Mary Snowden United States	7	276 1.1×	231 1.2×	77 0.5×	194 1.5×	49 0.4×	10	1.5k
Holly K. Van Houten United States	25	611 2.4×	299 1.5×	230 1.5×	138 1.1×	73 0.6×	75	2.4k

Countries citing papers authored by Dong‐Sook Kim

Since Specialization

Citations

This map shows the geographic impact of Dong‐Sook Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Sook Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Sook Kim more than expected).

Fields of papers citing papers by Dong‐Sook Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Sook Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Sook Kim. The network helps show where Dong‐Sook Kim may publish in the future.

Co-authorship network of co-authors of Dong‐Sook Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Sook Kim. A scholar is included among the top collaborators of Dong‐Sook Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Sook Kim. Dong‐Sook Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Chan Mi, Dong‐Sook Kim, & Inmyung Song. (2025). Comparison of generic drug prices in Korea and eight high-income countries across four therapeutic classes. PLoS ONE. 20(3). e0319674–e0319674.

Song, Inmyung & Dong‐Sook Kim. (2025). Cognitive impairment and domain‐specific life satisfaction among older adults: Findings from the Korean National Longitudinal Study on Aging. Geriatrics and gerontology international. 25(2). 182–189.

Song, Inmyung, Sukhyun Ryu, & Dong‐Sook Kim. (2024). Relationship between obesity, body composition, and pulmonary function among Korean adults aged 40 years and older. Scientific Reports. 14(1). 19798–19798. 2 indexed citations

Kim, Yong Chan, et al.. (2024). Quinolone Use during the First Trimester of Pregnancy and the Risk of Atopic Dermatitis, Asthma, and Allergies of Offspring during 2011 to 2020. Infection and Chemotherapy. 56(4). 461–461. 1 indexed citations

Cho, Hojin, et al.. (2024). The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study. Frontiers in Pharmacology. 15. 1382990–1382990. 4 indexed citations

Choi, Jun Yong, et al.. (2023). Antibiotic Use during Pregnancy in South Korea Using 2011–2020 National Health Insurance Claims Data. Antibiotics. 12(8). 1242–1242. 4 indexed citations

Shin, Ji Hye, et al.. (2023). Trends in National Pharmaceutical Expenditure in Korea during 2011 - 2020. Infection and Chemotherapy. 55(2). 237–237. 3 indexed citations

Kim, Do Young, Ho Yeong Lim, Jung‐Hwan Yoon, et al.. (2023). Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea. Gut and Liver. 18(1). 116–124. 1 indexed citations

Kim, Bongyoung, Song Vogue Ahn, Dong‐Sook Kim, et al.. (2022). Development of the Korean Standardized Antimicrobial Administration Ratio as a Tool for Benchmarking Antimicrobial Use in Each Hospital. Journal of Korean Medical Science. 37(24). e191–e191. 9 indexed citations

10.

Cho, Hojin, et al.. (2022). Factors related to polypharmacy and hyper‐polypharmacy for the elderly: A nationwide cohort study using National Health Insurance data in South Korea. Clinical and Translational Science. 16(2). 193–205. 14 indexed citations

11.

Noh, Yunha, Hyesung Lee, Jun Soo Kwon, et al.. (2022). First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: A population-based cohort study in South Korea. PLoS Medicine. 19(3). e1003945–e1003945. 25 indexed citations

12.

Lee, Jin Yong, et al.. (2022). Trends in orphan drug use and spending among children and adolescents during 2010–2020 in Korea. Frontiers in Pharmacology. 13. 964426–964426. 2 indexed citations

13.

Baek, Yae Jee, Young Ah Kim, Dokyun Kim, et al.. (2021). Risk Factors for Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Community-Onset Bloodstream Infection: Impact on Long-Term Care Hospitals in Korea. Annals of Laboratory Medicine. 41(5). 455–462. 8 indexed citations

14.

Kim, Hyun Jung, Taeuk Kang, Seo Young Sohn, et al.. (2021). Familial Risk of Hashimoto's Thyroiditis Among First-Degree Relatives: A Population-Based Study in Korea. Thyroid. 31(7). 1096–1104. 6 indexed citations

15.

Kim, Dong‐Sook, et al.. (2021). Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement. Frontiers in Bioengineering and Biotechnology. 9. 737504–737504. 6 indexed citations

16.

Kim, Bongyoung, Young Kyung Yoon, Dong‐Sook Kim, et al.. (2020). Development of Antibiotic Classification for Measuring Antibiotic Usage in Korean Hospitals Using a Modified Delphi Method. Journal of Korean Medical Science. 35(30). e241–e241. 5 indexed citations

17.

Kim, Hyun Jung, Hyeong Sik Ahn, Taeuk Kang, et al.. (2020). Familial Risk of Vitiligo among First-Degree Relatives and Spouses: A Population-Based Cohort Study in Korea. Journal of Investigative Dermatology. 141(4). 921–924.e3. 8 indexed citations

18.

Kim, Dong‐Sook, et al.. (2018). A Focus Group Interview Study of Prescribers, Pharmacists, Companies, and Policy Experts on the Same Price System to the Same Ingredient Medicines. 24(4). 1–23. 1 indexed citations

19.

Park, Chan Mi, Kun-Sei Lee, Euna Han, & Dong‐Sook Kim. (2016). Effects of delisting nonprescription combination drugs on health insurance expenditures for pharmaceuticals in Korea. Health Policy. 120(6). 590–595. 4 indexed citations

20.

Kim, Dong‐Sook, et al.. (2012). A Multi-level Analysis of Injection Requests and Associated Patient Characteristics in the Korean Acute-care Outpatient Setting. Korean Journal of Clinical Pharmacy. 22(1). 13–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact